<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04450381</url>
  </required_header>
  <id_info>
    <org_study_id>SDBB0004</org_study_id>
    <nct_id>NCT04450381</nct_id>
  </id_info>
  <brief_title>Noninvasive Hemoglobin Testing, Prospective Blood Donors</brief_title>
  <official_title>Noninvasive Hemoglobin Testing in Prospective Blood Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical investigation is to evaluate the pulse oximeter devices for
      screening prospective blood donors. The purpose study is to report on the accuracy of
      noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a
      laboratory hematology analyzer in a blood donation setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 23, 2020</start_date>
  <completion_date type="Actual">July 7, 2020</completion_date>
  <primary_completion_date type="Actual">July 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rad-67 sensitivity and specificity</measure>
    <time_frame>Up to one hour per subject</time_frame>
    <description>Sensitivity and specificity of the the Rad-67 will be determined for its use in a blood donation center</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">131</enrollment>
  <condition>Healthy</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Test subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects are enrolled and receive Rad-67 Pulse oximeter &amp; DCI Mini sensor for measurement of hemoglobin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rad-67 Pulse oximeter &amp; DCI Mini sensor</intervention_name>
    <description>Noninvasive pulse oximeter that measures hemoglobin</description>
    <arm_group_label>Test subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age

          -  Weight at least 110 pounds

          -  Subjects with the intention of being screened for eligibility to donate blood

          -  The subject has given written informed consent to participate in the study

        Exclusion Criteria:

          -  Subjects with skin abnormalities at the planned application sites that may interfere
             with sensor application, per directions-for-use (DFU) or trans-illumination of the
             site, such as burns, scar tissue, infections, abnormalities, etc.

          -  Subjects unwilling and/or unable to remove nail polish or acrylic nails

          -  Subjects with blood cancers such as leukemia

          -  Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia

          -  Subjects with known history of infectious diseases such as HIV/AIDS, syphilis,
             hepatitis, etc.

          -  Subjects with self-disclosed/known pregnancy at the time of enrollment

          -  Subjects deemed not suitable for the study at the discretion of the investigator

          -  Excessive motion includes postural changes, making hand gestures, involuntary muscular
             movements, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Blood Bank - Site 1</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 25, 2020</study_first_submitted>
  <study_first_submitted_qc>June 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

